[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C][Branch2][Ring1][=Branch2][C@@H1][C][C][C@][Ring1][Branch1][Branch1][Branch2][C][=Branch1][C][=O][C][Ring1][#Branch1][C][S][=Branch1][C][=O][=Branch1][C][=O][O][C].[C][N][C][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][=C][C][C][N][C][=Branch1][C][=O][C][=C][Ring1][Branch2][C][=Branch1][=Branch2][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][F][N][Ring1][#C]"}, {"from": "gpt", "value": "The molecule is a camphorsulfonate salt obtained by reaction of rucaparib with one molar equivalent of (1S,4R)-camphorsulfonic acid. It is an inhibitor of poly (ADP-ribose) polymerase and is used as monotherapy for advanced ovarian cancer and deleterious germline or somatic BRCA mutation. It has a role as an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor. It is a camphorsulfonate salt and an azepinoindole. It contains a (S)-camphorsulfonate and a rucaparib(1+)."}]